Qualigen Therapeutics, Inc.

Contributing Author

Recent Articles by Qualigen Therapeutics, Inc.

Oct-27	Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025 QLGN GlobeNewswire
Oct-23	Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation QLGN GlobeNewswire
Oct-12	Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For? QLGN GlobeNewswire
Oct-06	Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition QLGN GlobeNewswire
Sep-30	Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto QLGN GlobeNewswire
Sep-19	Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) f for Crypto Business Through PIPE Transaction QLGN GlobeNewswire
Jul-28	Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status QLGN GlobeNewswire
Jul-28	Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock QLGN GlobeNewswire
Jul-16	Qualigen Granted New Patents Covering 25 Countries QLGN GlobeNewswire
May-19	Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q QLGN GlobeNewswire
May-01	Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K QLGN GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.